Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
94856 trials found · Page 143 of 4743
-
New spinal implant aims to ease tough chronic pain in 970-Patient trial
Disease control Recruiting nowThe PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Sponsor: Medtronic • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could a diabetes drug curb heavy drinking in HIV patients?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the drug semaglutide works to reduce alcohol intake among adults living with HIV. The main questions it aims to answer are: 1. Does semaglutide lower the average number of alcoholic beverages participants drink per week? 2. Does sem…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New shot could soothe severe eczema in teens
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel group study to confirm the efficacy and safety of MG-K10 monotherapy in adolescents with moderate-to-severe atopic dermatitis (AD)
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New inhaled drug aims to help PAH patients walk farther
Disease control Not yet recruitingThe primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Shocking prostate cancer: new electrical pulse may replace radiation boost
Disease control Recruiting nowIn this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard s…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 22:49 UTC
-
New combo therapy aims to tame lymphoma with less radiation damage
Disease control Recruiting nowThis is a prospective, multicenter Phase 2 clinical trial named the MALT-RO study, evaluating ultra-low-dose radiation therapy followed by orelabrutinib as first-line treatment for adults with Stage I-II MALT lymphoma. The study aims to determine the efficacy and safety profile o…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug aims to stop chemo hair loss in its tracks
Prevention Not yet recruitingClinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Phase: PHASE1, PHASE2 • Sponsor: Applied Biology, Inc. • Aim: Prevention
Last updated May 15, 2026 11:58 UTC
-
New drug aims to reverse deadly wasting in cancer patients
Symptom relief Recruiting nowA study of how well and safely a new drug called visugromab works in people with certain kinds of cancer (including lung and bowel cancer) and unintended weight loss known as cachexia. The main questions it aims to answer are: * Does visugromab help participants put weight back …
Phase: PHASE2, PHASE3 • Sponsor: CatalYm GmbH • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
Smart drug delivers chemo directly to cancer cells in new trial
Disease control Recruiting nowThis is a Phase 1/2a open-label multicenter study to evaluate the safety, efficacy, and pharmacokinetics of CKD-703 in Advanced c-Met Expressing Solid Tumors, and in MET-Amplified and c-Met Overexpressing Non-Small Cell Lung Cancer. CKD-703 is composed of a c-Met-targeting monoc…
Phase: PHASE1, PHASE2 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for kidney transplant patients: drug shows promise in fighting rejection Long-Term
Disease control ENROLLING_BY_INVITATIONIn this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and then developed a condition called antibody-mediated rejection (AMR). AMR happens when the body's immune system creates antibodies that attack the transpl…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New Same-Day HPV test could save lives in remote areas
Diagnosis Not yet recruitingIn high-income countries, prevention strategies have led to declines in cervical cancer rates by more than 75% in high-income countries. In contrast, low- and middle-income countries (LMICs) carry the global burden of cervical cancer with about 85% of new cases and 90% mortality.…
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated May 07, 2026 18:43 UTC
-
New pill could help cancer patients avoid dangerous platelet drops
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of of Hetrombopag Olamine Tablets Vs Placebo in Patients with Chemotherapy-Induced Thrombocytopenia.
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Gene therapy aims to free kids with rare anemia from lifelong blood transfusions
Disease control Recruiting nowBrief summary The goal of this clinical trial is to learn if APR-2020 is safe and can help treat Diamond-Blackfan Anemia (DBA) in adolescents and children. The main questions it aims to answer are: * Is APR-2020 safe and well tolerated? * Does APR-2020 modify or correct an unde…
Phase: PHASE1 • Sponsor: Apriligen, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New heart preservation method could save more lives
Disease control Recruiting nowHOPE for All is a clinical investigation to support the use of hypothermic oxygenated perfusion (HOPE) using a revised XVIVO Heart Assist Transport System in a real- world setting. The trial will investigate the application of HOPE in a broad population of Donation after Brain D…
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for kids with severe colitis: drug trial seeks remission
Disease control Recruiting nowThis Phase III, randomized, double-blind, multicenter, induction and maintenance study will evaluate the safety and efficacy of Afimkibart (RO7790121) in pediatric participants with moderate to severe active ulcerative colitis (UC).
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a phone app speed up opioid addiction treatment? new study aims to find out
Disease control Not yet recruitingThis trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Targeted chemo injection shows promise in pancreatic cancer trial
Disease control Not yet recruitingthis is a randomized controlled trial aims to compare between patients with locally advanced pancreatic cancer treated with EUS-guided injection of gemcitabine in addition to systemic chemotherapy, versus those who treated with the standard systemic chemotherapy alone, regarding …
Phase: PHASE2, PHASE3 • Sponsor: Assiut University • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
New hope for lymphoma patients after CAR t fails: glofitamab trial launches
Disease control Not yet recruitingThis is a Phase 2, multicentre, single arm study that evaluates the efficacy and safety of glofitamab in MCL patients with inadequate response or relapse following CAR T-cell therapy.
Phase: PHASE2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
New hope for Drug-Resistant ovarian cancer? phase 3 trial launches
Disease control Not yet recruitingThis is a randomized, Phase 3 trial designed to evaluate the efficacy and safety of azenosertib compared to Investigator's choice of chemotherapy in subjects with platinum-resistant ovarian cancer whose tumors are positive for cyclin E1 protein expression.
Phase: PHASE3 • Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New hope for rare, aggressive blood cancer: drug duo enters trial
Disease control Recruiting nowThis phase II trial tests how well nemtabrutinib in combination with pembrolizumab works in treating patients with Richter transformation, diffuse large B-cell lymphoma subtype (RT-DLBCL). Nemtabrutinib is in a class of medications called kinase inhibitors. It blocks a protein ca…
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:39 UTC